Pfizer Inc (PFE)

455.2
+4.4(+0.98%)
  • Volume:
    25,692
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    450.8 - 456.8
Unusual trading volume

Pfizer has doubled (or more) its daily average of shares traded over the last 3 months. High volumes usually indicate new trends and larger share price movements.

PFE Overview

Prev. Close
450.8
Day's Range
450.8-456.8
Revenue
76.04B
Open
450.8
52 wk Range
424.5-571
EPS
5.31
Volume
25,692
Market Cap
2.54T
Dividend (Yield)
1.64
(3.63%)
Average Vol. (3m)
10,075
P/E Ratio
8.30
Beta
0.651
1-Year Change
-10.08%
Shares Outstanding
5,613,314,537
Next Earnings Date
May 02, 2023
What is your sentiment on Pfizer?
or
Market is currently closed. Voting is open during market hours.

Pfizer Inc News

Pfizer Inc Analysis

Pfizer Inc Company Profile

Pfizer Inc Company Profile

Employees
79000
  • Type:Equity
  • Market:Sweden
  • ISIN:US7170811035
  • S/N:6633982

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.

Read More

Analyst Price Target

Average55.4 (+26.5% Upside)
High75.0
Low44.0
Price43.79
No. of Analysts20
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellNeutral
Technical IndicatorsSellBuyStrong BuyStrong SellSell
SummarySellNeutralNeutralStrong SellNeutral
  • Project veritage video is going viral ,timber!
    0
    • This turdsucker is easy money short short and short again
      1
      • Pfizer is the best short stock ever. I always like to short this worthless stock.
        3
        • short this trash scam to the ground
          4
          • on the decline due to not telling about all the adverse reactions to shots. just general info
            2
            • Buy
              3
              • shorts are being sold
                0
                • Pfizer will turn to his previous of 30-35 monthly. Until another pandemic blow as the monkey pox did not had enough impact. Hope that AstraZeneca and Russian Sputnik do not have the same impact. Just saying...
                  2
                  • Pfizer is 100% manipulated by the CEO and other insiders. That's why its stock price will never go up.
                    2
                    • I wish it closes in green today
                      1
                  • AstraZeneca goes high everyday, but Pfizer keeps falling... that is why the billionaires are not interested in Pfizer.
                    0
                    • Astras doomed days are on tge horizon
                      0